S&P 500 Healthcare Sector SEC Filings — April 22, 2026

22-04-2026

Stifel Financial Corp reported record first quarter 2026 net revenues of $1.48 billion, up approximately 18% YoY from $1.26 billion, driven by 44% higher investment banking revenues (advisory +59%, capital raising +22%) and 12% growth in asset management revenues, with net income available to common shareholders surging to $242.1 million ($1.48 diluted EPS) from $43.7 million ($0.26 EPS) a year ago impacted by legal provisions. Global Wealth Management net revenues rose 10% to $932.1 million with client assets up 11% to $538.7 billion, while Institutional Group revenues increased 29% to $495.3 million. However, Institutional equity transactional revenues declined 7% YoY to $55.4 million due to European Equities restructuring, and investment banking revenues fell 25% QoQ from Q4 2025.

• ·Sale of Stifel Independent Advisors, LLC closed February 2, 2026, with gain recognized in revenues; included $9.0B client assets and $4.2B fee-based assets.
• ·Three-for-two stock split declared January 26, 2026, effective February 26, 2026 (record date February 12, 2026).
• ·Quarterly dividend of $0.34 per common share payable March 16, 2026 (record March 2, 2026).
• ·Tangible book value per common share $24.89, up 12% YoY.
• ·Tier 1 common capital ratio 15.8% (up from 14.7% YoY); Tier 1 capital $4,530M.
• ·Fitch BBB+ Stable, S&P BBB Stable.

22-04-2026

Amgen announced the retirement of David M. Reese, M.D., Executive Vice President and Chief Technology Officer, effective June 30, 2026, following his contributions to innovative medicines, biosimilars, pipeline advancement, and early adoption of AI in R&D since joining in 2005. Effective June 1, 2026, organizational changes to emphasize convergent innovation include appointing James Bradner, M.D., as EVP Research and Development, Artificial Intelligence and Data; Sean Bruich as SVP Chief Technology Officer; Murdo Gordon as EVP Amgen Global Markets and Policy; with Paul Burton, M.D., Ph.D., continuing as SVP Chief Medical Officer. These adjustments aim to integrate biology, data science, and advanced technologies to accelerate medicine discovery and enhance patient engagement.

• ·David M. Reese joined Amgen in 2005 as clinical development leader in oncology; served as EVP R&D from 2018 to 2023.
• ·Amgen part of Dow Jones Industrial Average and Nasdaq-100 Index.
• ·Contacts: Elissa Snook (media, 609-251-1407); Casey Capparelli (investors, 805-447-1746).

22-04-2026

CACI reported fiscal Q3 2026 revenues of $2,351.0 million, up 8.5% YoY (6.8% organic), net income of $130.4 million (up 16.6%), diluted EPS of $5.88 (up 17.6%), and EBITDA of $289.7 million (up 14.3%, including $17.4 million ARKA transaction expenses). The company completed its $2.6 billion all-cash acquisition of ARKA Group and raised FY2026 revenue guidance to $9,500-$9,600 million and EBITDA margin to 11.8%-11.9%, while slightly lowering adjusted net income guidance to $615-$630 million and reaffirming free cash flow at least $725 million; DSO remained flat at 55 days. Total backlog grew 6.4% YoY to $33.4 billion.

• ·Notable Q3 contract awards: $371M intelligence community extension, $306M DAI Global Model task order, $287M IPPS-A technology contract, $231M U.S. Special Operations Command task order, $85M NSWC Carderock task order
• ·FY2026 guidance: Adjusted diluted EPS $27.70-$28.38; Diluted weighted average shares 22.2
• ·Nine months FY26 revenues $6,858.722 million, up 8.5% YoY
• ·CACI named Fortune World’s Most Admired Company for ninth consecutive year, advancing to sixth in category

22-04-2026

Bankwell Financial Group reported Q1 2026 GAAP net income of $11.3 million ($1.41 per diluted share), up from $9.1 million ($1.15 per share) in Q4 2025, driven by core deposit growth of $113 million (including $39 million in low-cost deposits) and net loan growth of $27.1 million. However, net interest margin declined 12 basis points to 3.28%, noninterest expense increased $1.4 million to $16.9 million, PPNR fell 10.2% to $13.3 million, and nonperforming loans rose $2.7 million to $19.0 million (0.66% of total loans). The board declared a $0.20 per share dividend payable May 19, 2026, to shareholders of record on May 8, 2026.

• ·SBA loan sale gains increased to $2.4 million in Q1 2026 from $2.2 million in Q4 2025.
• ·Opened first full-service branch in New York State on February 20, 2026, in Bay Ridge, Brooklyn.
• ·Brokered deposits declined $44.5 million (8.0%) and FHLB borrowings $50.0 million QoQ; reduced brokered deposits by $512.4 million (49.9%) since December 31, 2022 peak.
• ·Credit for credit losses - loans of $1.0 million in Q1 2026; ACL-Loans coverage of nonperforming loans at 155.39%.
• ·Guidance: non-interest expense $64-65M full year 2026; non-interest income increased to $12-13M.
• ·Conference call scheduled for April 23, 2026, at 9:00 a.m. ET.

22-04-2026

Absci Corporation (ABSI) filed its DEF 14A proxy statement for the virtual Annual Meeting of Stockholders on June 4, 2026, at 9:00 a.m. ET, with a record date of April 7, 2026, when 155,447,428 shares of common stock were outstanding, requiring a quorum of 77,723,715 shares. The meeting includes Proposal 1 (election of Class II directors, non-routine) and Proposal 2 (ratification of Ernst & Young LLP as independent auditors for the year ending December 31, 2026, routine). The company qualifies as an emerging growth company until the earliest of December 31, 2026, $1.235 billion annual gross revenue, $1 billion in nonconvertible debt over three years, or $700 million public float triggering large accelerated filer status.

• ·Proxy materials available on or about April 22, 2026, via www.proxyvote.com or www.sec.gov.
• ·Voting deadline: 11:59 p.m. ET on June 3, 2026, for Internet/telephone/mail; live voting at virtual meeting.
• ·Corporate address: 18105 SE Mill Plain Blvd, Vancouver, WA 98683, Attention: Corporate Secretary.
• ·Technical support for virtual meeting: (844) 986-0822 (U.S.) or (303) 562-9302 (International).

22-04-2026

NewHold Investment Corp IV, a blank check company, consummated its initial public offering (IPO) on April 16, 2026, selling 20,125,000 units at $10.00 per unit, generating gross proceeds of $201,250,000, including the full exercise of the underwriter's over-allotment option for 2,625,000 units. Simultaneously, the Company completed a private placement of 641,250 units at $10.00 per unit for aggregate proceeds of $6,412,500 to its Sponsor (440,000 units) and BTIG, LLC (201,250 units). A total of $201,250,000 from the net IPO proceeds and private placement was placed in trust, with the audited balance sheet as of April 16, 2026, showing total assets of $203,605,000 and shareholders' deficit of $5,287,000.

• ·Current assets outside trust: $2,355,000 (including cash $2,017,000, due from Sponsor $158,000, prepaid expenses $180,000)
• ·Current liabilities: $598,000 (accounts payable – offering costs $318,000, accrued expenses $280,000)
• ·Class A ordinary shares subject to redemption: 20,125,000 shares at $10.00 per share totaling $201,250,000
• ·Company incorporated October 6, 2025; fiscal year end December 31

22-04-2026

Pinnacle Financial Partners reported Q1 2026 financial results significantly impacted by its merger with Synovus Financial Corp., closed January 1, 2026, driving loans to $85,197 million (up 118% linked-quarter from $39,154 million and up from $36,137 million YoY) and deposits to $100,103 million (up 111% LQ from $47,401 million and 125% YoY from $44,482 million). Reported diluted EPS declined 50% YoY to $0.89 with net income available to common shareholders at $135 million (down 1% YoY from $136 million), primarily due to $275.4 million in merger-related expenses, though adjusted diluted EPS increased 26% YoY to $2.39. Net interest margin expanded 26 bps LQ to 3.53%, but efficiency ratio worsened to 77.4% while adjusted tangible efficiency was 51.3%; credit quality held with NPA ratio at 0.58% (up from 0.36% LQ) and NCO ratio at 0.23%.

• ·Common Equity Tier 1 (CET1) ratio preliminary at 9.83%
• ·Allowance coverage of non-performing loans at 221%
• ·Hiring of 50 experienced revenue producers in Q1 2026 vs 41 in combined 4Q25 and 45 in combined 1Q25
• ·Conference call scheduled for April 23, 2026 at 8 a.m. ET
• ·Assets total $123 billion as of reporting

22-04-2026

Elevance Health reported Q1 2026 operating revenue of $49.5 billion, up 1.5% YoY from $48.8 billion, driven by higher premium yields and CarelonRx growth, with adjusted diluted EPS of $12.58 exceeding expectations. However, operating gain fell 34.2% to $2.1 billion from $3.2 billion due to a $935 million CMS accrual, $129 million business optimization charge, and higher Medicaid medical costs, while key memberships like Medicare Advantage declined 15.8% YoY and Health Benefits operating gain dropped 2.7%. The company raised FY 2026 adjusted diluted EPS guidance to at least $26.75 and reaffirmed operating cash flow of at least $5.5 billion.

• ·Days in Claims Payable: 46.6 days as of Mar 31 2026, up 3.8 days YoY
• ·Q1 2026 dividend: $1.72 per share; Q2 dividend declared $1.72 per share payable June 25 2026
• ·Share repurchase authorization remaining: $5.6 billion as of Mar 31 2026
• ·CarelonRx quarterly adjusted scripts: 80.3 million, down 4.3% YoY

22-04-2026

Mason & Associates, LLC filed its 13F-HR report disclosing $436,700,651 in total holdings across 44 positions as of March 31, 2026. The portfolio is heavily weighted toward ETFs, with the largest positions being iShares Core USD Universal ETF at $133,823,978 and Vanguard Index Funds Large Cap ETF at $128,226,075. Other significant holdings include PIMCO ETF TR Multisector Bond at $25,857,409 and BlackRock ETF Trust iShares US Equity at $22,472,374.

• ·Filed on April 22, 2026 for period ending March 31, 2026
• ·Business address: 2 Bayport Way, Suite 110, Newport News, VA 23606
• ·All positions reported as SH SOLE with no other voting or shared discretion indicated

22-04-2026

Citrine Capital LLC filed its 13F-HR on April 22, 2026, disclosing total holdings valued at $230,653,067 across 58 positions as of March 31, 2026. The portfolio features significant allocations to Dimensional ETF Trust products, including US Sustainability ($56.7M) and California Municipal Bond ETF ($39.2M), alongside NVIDIA Corporation ($32.5M, 186,627 shares), and other tech names like Apple, Microsoft, Amazon, and Bitcoin-related ETFs. All positions are held with sole voting authority, reflecting a diversified mix of equities, ETFs, and alternative assets.

• ·Filing period end date: March 31, 2026
• ·Date as of change: April 21, 2026
• ·Business address: 535 Mission Street, 14th Floor, San Francisco, CA 94105
• ·All holdings reported with sole shared discretion and voting authority (0 other managers)

22-04-2026

Foundry Financial LLC filed its 13F-HR on April 22, 2026, disclosing 71 holdings totaling $236058007 as of March 31, 2026, all with sole discretionary voting authority. The portfolio is dominated by Dimensional ETF Trust products, with top positions including US Equity Market (47736948 value, 673205 shares), US High Profitab (18211369 value, 495413 shares), Intl Core Equity (15557420 value, 437867 shares), US Large Cap Val (15248142 value, 426999 shares), and Short Duration F (14880420 value, 310786 shares). Notable individual stock holdings include Alphabet Inc Cl A (787635 value, 2739 shares), Amazon.com Inc (1047257 value, 5028 shares), and Apple Inc (609487 value, 2402 shares).

• ·All positions held with sole voting authority (SH SOLE); no shared discretion, puts, or calls reported
• ·Business address: 479 S Marengo Ave, Pasadena, CA 91101
• ·SEC file number: 028-26517
• ·Conformed period of report: 2026-03-31

22-04-2026

Hofer & Associates, Inc. disclosed $186,078,076 in total holdings across 64 positions in its 13F-HR filing for the period ended March 31, 2026, consisting entirely of sole ownership in U.S. equities and ETFs with no other investment discretion reported. Key positions include large SPDR ETFs (e.g., $20.4M in one SPDR Series Trust), Apple Inc. ($5.6M, 22,193 shares), NVIDIA Corp. ($5.1M, 29,405 shares), and Microsoft Corp. ($2.5M, 6,650 shares). No prior period data is provided in the filing for comparison.

• ·Filing date: April 22, 2026
• ·Report period end: March 31, 2026
• ·All positions held as sole voting and sole investment discretion (SH SOLE)
• ·No put/call options or other manager discretion reported

22-04-2026

Benchmark Financial, LLC filed its quarterly 13F-HR on April 22, 2026, disclosing total holdings of $111,438,399 as of March 31, 2026, across 52 positions held solely. The portfolio is diversified with significant allocations to SPDR and Vanguard ETFs, alongside individual stocks such as CleanSpark Inc (124,000 shares valued at $1,055,240) and Alphabet Inc (1,133 shares valued at $325,878). No prior period changes or performance metrics are provided in the filing.

• ·Holdings consist entirely of sole discretionary positions (SH SOLE).
• ·Other notable positions: Microsoft Corp (3,458 shares, $1,279,924), Berkshire Hathaway Inc DEL CL B NEW (2,247 shares, $1,076,762).
• ·Heavy emphasis on ETFs including fixed income, equity premium, and index trackers.

22-04-2026

News Corporation disclosed via 8-K information provided to the Australian Securities Exchange (ASX) on specific dates regarding its ongoing $1 billion stock repurchase program for Class A (NWSA) and Class B (NWS) common stock. The disclosures are required daily by ASX rules if transactions occur under the program, with details attached as Exhibits 99.1 and 99.2. No specific transaction amounts or volumes were detailed in the filing body.

22-04-2026

Larry Mathis Financial Planning, LLC disclosed holdings totaling $111,545,722 across 156 positions as of March 31, 2026, in its 13F-HR filing submitted April 22, 2026. All positions are held with sole discretionary voting authority, featuring a diversified mix of equities and ETFs including Dimensional ETF Trust US Core Equity Market (184,359 shares valued at $8,318,286) and iShares Trust 0-1 Year Treasury Bond ETF (51,532 shares valued at $5,688,617). No changes from the prior quarter were reported.

• ·CIK: 0002118274
• ·Business address: 7210 N 16TH STREET, PHOENIX, AZ 85020
• ·Phone: 6023930501
• ·All holdings reported as SH SOLE (sole discretionary authority)

22-04-2026

Decision Investments, Inc. filed its 13F-HR on April 22, 2026, disclosing U.S. equity holdings as of March 31, 2026, totaling $87,934,619 across 140 positions, all held with sole voting and dispositive power. The portfolio is heavily concentrated in technology stocks and ETFs, with the largest holding in NVIDIA CORP at $18,747,128 (107,495 shares), followed by Lam Research Corp at $5,247,276 (24,559 shares) and Apple Inc. at $3,723,738 (14,673 shares). No changes, short positions, or options are indicated in the filing.

• ·Filing period end date: March 31, 2026
• ·All positions reported as SH SOLE with no shared voting/dispositive power, puts, calls, or other manager categories
• ·Company address: 4445 Eastgate Mall, Ste 200, San Diego, CA 92121

22-04-2026

Sherrill & Hutchins Financial Advisory, Inc. filed its quarterly 13F-HR report as of March 31, 2026, disclosing total portfolio holdings valued at $169303049 across 15 positions, all held with sole investment discretion. Top holdings by value include Vanguard Scottsdale Fds VNG Rus1000Idx at $46482996, Fidelity Merrimack Str Tr Total Bd ETF at $41312517, and American Centy ETF Tr US Sml Cp Valu at $33816788. No period-over-period changes or performance metrics are provided in the filing.

• ·Filing submitted on April 22, 2026, for period ended March 31, 2026
• ·All positions held with SOLE investment discretion
• ·Central Index Key: 0002005607
• ·SEC File Number: 028-23510

22-04-2026

Financial Planning Navigators CORP filed its Form 13F-HR for the quarter ended March 31, 2026, disclosing a portfolio of 51 holdings with a total market value of $228,135,477. The largest positions are ETFs including Vanguard Index Fds Large Cap ETF ($53,329,014), Vanguard Tax-Managed Fds Van Ftse Dev Mkt ($46,438,020), and Schwab Strategic Tr Us Mid-Cap ETF ($23,095,784), with additional allocations to individual stocks such as Apple Inc ($1,865,981), Nvidia Corp ($1,742,265), and Microsoft Corp ($1,169,185). No changes or performance metrics were detailed in the filing.

• ·Report period end: 03-31-2026
• ·Filing date: 04-22-2026
• ·Business address: 7365 Kirkwood Court N, Suite 330, Maple Grove, MN 55369
• ·State of incorporation: MN
• ·Fiscal year end: 12-31
• ·All reported holdings held with sole voting and disposition power

22-04-2026

Pinnacle Associates Ltd filed its 13F-HR on April 22, 2026, reporting institutional equity holdings as of March 31, 2026, with a diverse portfolio spanning technology, healthcare, financials, and other sectors. Top holdings include Apple Inc valued at $310,546,564,000 with 1,223,636 shares (sole voting authority 1,208,704 shares), Broadcom Inc at $139,233,779,000 with 449,852 shares, and Amazon.com Inc at $111,545,555,000 with 535,581 shares. The filing provides a snapshot of approximately 300 positions with breakdowns of sole, shared, and other voting authority shares, showing no overall portfolio performance metrics or changes from prior periods.

• ·Filer CIK: 0000743127
• ·SEC File Number: 028-01669
• ·Business Address: 335 Madison Avenue, 11th Floor, New York, NY 10017
• ·Signed by: /s/ Scott M. Brown on April 21, 2026

22-04-2026

Stolz & Associates, PS filed a 13F-HR on April 22, 2026, disclosing 30 holdings totaling $143300724 thousand (or $143.3B) in market value as of March 31, 2026. The portfolio is diversified across tech stocks including Alphabet ($209M), Amazon ($291M), Apple ($521M), Microsoft ($687M), Nvidia ($2288M), and Broadcom ($238M), alongside significant allocations to Dimensional ETFs such as US High Profitab ($28590M), Global Core Plus ($15175M), and Intl High Profit ($14505M). Fixed income and small-cap ETFs from iShares, Vanguard, Schwab, American Century, and others comprise the balance, with no reported changes in voting authority (all sole).

• ·Filing CIK: 0002108989
• ·SEC file number: 028-26108
• ·Adviser ID: 801-117720
• ·Business address: 3102 Ruston Way, Tacoma, WA 98402
• ·Phone: 253-272-3441
• ·All positions held with sole voting authority; no shared or other voting reported
• ·Date as of change: 2026-04-21

22-04-2026

Biltmore Wealth Management, LLC filed its 13F-HR on April 22, 2026, disclosing 60 securities holdings totaling $281,197,886 as of March 31, 2026. The portfolio features large positions in Select Sector SPDR ETFs including Industrial ($34,468,911), Technology ($29,054,862), and Health Care ($25,627,404), alongside PIMCO municipal bond ETFs ($21,114,769 and $18,519,977) and stocks like Apple Inc ($1,542,800 for 6,079 shares). No prior period comparisons or changes are provided in the filing.

• ·All positions reported with sole shared voting authority and no other managers.
• ·Business address: 1400 E Southern Avenue, Suite 650, Tempe, AZ 85282.
• ·SEC file number: 028-16482.

22-04-2026

Spruce Biosciences, Inc. (NASDAQ: SPRB) announced a proposed underwritten public offering of shares of its common stock or pre-funded warrants, with joint book-running managers Leerink Partners, Guggenheim Securities, and Oppenheimer & Co., and co-managers Jones and Craig-Hallum. The company expects to grant underwriters a 30-day option to purchase up to 15% additional shares at the public offering price, less discounts. The offering is subject to market conditions, with no assurance on completion, size, or terms, and is made pursuant to a shelf registration on Form S-3 effective November 26, 2025.

• ·Shelf registration on Form S-3 filed October 29, 2025, declared effective November 26, 2025.
• ·Announcement date: April 20, 2026.
• ·SEC filing date: April 22, 2026.

22-04-2026

Ketron Financial, an institutional investment manager, filed its Form 13F-HR disclosing holdings as of March 31, 2026, with a total portfolio market value of $279337878 across 55 positions, all held with sole voting power. Top holdings by value include NVIDIA Corporation at $123959052, Alphabet Inc. CAP STK CL A at $19034732, and Amazon.com Inc. at $10425158. The portfolio features heavy concentration in technology stocks and diversified ETFs with no reported changes or performance metrics.

• ·All 55 positions held with sole discretionary and voting power (SH SOLE).
• ·Filing covers period ending March 31, 2026, submitted April 22, 2026.

22-04-2026

Shinhan Financial Group's total gross loans grew to W 469,768 billion as of December 31, 2025, up 3.3% YoY from W 455,125 billion in 2024 and 9.0% from W 417,346 billion in 2023. However, the allowance for credit losses as a percentage of total loans declined to 0.91% from 1.00% YoY, coverage of impaired loans fell to 111.89% from 122.66%, and non-performing loans ratio was nearly flat at 0.57% versus 0.58% prior year. Risks highlighted include potential deterioration in credit card receivables asset quality due to market changes and stricter regulations.

• ·Risk of reduced revenues and deterioration in asset quality of credit card receivables due to market changes and stricter regulation.
• ·Potential national budget deficit from decreased tax revenues or increased government expenditures on stimulus, unemployment, and social programs.

22-04-2026

Boston Scientific reported Q1 2026 net sales of $5.203 billion, up 11.6% on a reported basis and 9.4% on an operational and organic basis YoY, driven by 13.5% reported growth in Cardiovascular, but MedSurg grew only 7.8% reported with Urology flat at 0.5% organic and EMEA operational growth at just 1.2%. GAAP net income attributable to common stockholders reached $1.341 billion or $0.90 per share, more than doubling from $674 million or $0.45 per share YoY, while adjusted EPS increased to $0.80 from $0.75. The company completed the acquisition of Valencia Technologies and highlighted positive clinical trial results for WATCHMAN FLX, EKOS, and FARAPULSE.

• ·Full year 2026 organic net sales guidance: 6.5% to 8.0%; adjusted EPS $3.34 to $3.41.
• ·Q2 2026 organic net sales guidance: 5.0% to 7.0%; adjusted EPS $0.82 to $0.84.
• ·Received NMPA approval in China for OPAL HDx™ Mapping System.
• ·Received U.S. FDA 510(k) clearance for Asurys™ Fluid Management System.
• ·Elected Cathy Smith and Christophe Weber to the board of directors.

22-04-2026

On April 18, 2026, the Board of Directors of Jade Biosciences, Inc. (JBIO) appointed Andrew King, BVMS, Ph.D. as President, Research & Development, effective immediately. Dr. King previously served as the Company’s Chief Scientific Officer and Head of Research & Development. No changes were made to Dr. King’s compensation in connection with the appointment.

• ·Filing date: April 22, 2026
• ·Event date: April 18, 2026
• ·Principal executive offices: 221 Crescent St., Building 23, Suite 105, Waltham, MA 02453

22-04-2026

Civista Bancshares reported first-quarter 2026 net income of $15.0 million, a 47% increase YoY from $10.2 million and 22% QoQ from $12.3 million, with diluted EPS of $0.72 up 9% YoY and 18% QoQ, supported by net interest margin expansion to 3.85% (up 34 bps YoY) and lower cost of funds to 196 bps. However, total assets declined $38.1 million or 0.9% QoQ to $4.3 billion, loans decreased $40.4 million or 1.2% QoQ due to seasonal construction runoff and payoffs, and non-recurring merger-related costs negatively impacted net income by $0.4 million. Deposits grew modestly $35.4 million or 1.0% QoQ to $3.5 billion, efficiency ratio improved to 60.1% from 64.9% YoY, and ROA rose to 1.41%.

• ·Non-performing assets $30.2 million (0.70% of assets) at March 31, 2026, down 3.3% QoQ.
• ·Declared quarterly cash dividend of $0.18 per share (up from $0.17 prior quarter), yielding 3.16% annualized at $22.79 share price.
• ·Tangible book value per share $19.70 at March 31, 2026.
• ·Net charge-offs $0.7 million Q1 2026 vs $0.6 million Q1 2025.

22-04-2026

TuHURA Biosciences announced a $50 million credit facility from an affiliate of its largest stockholder, K&V Investment One LLC, providing non-dilutive funding to extend cash runway into 2028 for pipeline development, including IFx-2.0 through Phase 3 results and TBS-2025 to key efficacy milestones. The facility allows monthly draws as needed at 12% annual interest, secured by company assets, with principal due at 5-year maturity on April 21, 2031, and includes a low to mid-single digit royalty on IFx-2.0 commercial sales. No declines or flat metrics reported; forward-looking risks include potential inability to draw funds or insufficient coverage for operations.

• ·Draws available monthly on as-needed basis for clinical development and operations
• ·Interest paid monthly; principal repayment at maturity on April 21, 2031
• ·Low to mid-single digit royalty on annual commercial sales of IFx-2.0 by Company or sublicensees
• ·Merger with Kineta Inc. on June 30, 2025 acquired TBS-2025
• ·10-K for fiscal year ended December 31, 2025 filed March 31, 2026

22-04-2026

New Mountain Guardian IV BDC, L.L.C. disclosed its consolidated portfolio investments classification as of December 31, 2025, categorizing them into 11 industry types with sub-classifications. Business Services represented the largest portion at 36.3% of total investments at fair value, followed by Software at 28.9%, Financial Services & Technology at 14.3%, and Healthcare at 10.6%, while smaller categories included Consumer Services at 5.0% and Education at 2.1%. This information is furnished under Item 7.01 and not deemed filed.

• ·Portfolio classified into 11 industry types for quarterly Form 10-Q and annual Form 10-K reporting.
• ·Sub-classifications assigned for internal monitoring to reflect business mix.
• ·Disclosure date: April 22, 2026; portfolio date: December 31, 2025.

22-04-2026

AtlasMark Financial, Inc. filed a Form 13F-HR disclosing its institutional equity holdings as of June 30, 2021, with a total market value of $76,333,712 across 39 positions, all held with sole voting power. The portfolio features heavy ETF exposure, including Invesco QQQ Trust ($17,792,386, 50,200 shares), iShares Core S&P 500 ETF ($8,053,691, 18,733 shares), and iShares Core S&P Mid-Cap ETF ($5,344,234, 19,887 shares), alongside stocks like Apple Inc. ($591,119, 4,316 shares) and Microsoft Corp. ($1,584,223, 5,848 shares). No prior period comparisons, performance metrics, or changes were disclosed.

• ·Holdings period end date: June 30, 2021
• ·Filing date: April 22, 2026
• ·All reported positions held with sole voting power (no shared power indicated)
• ·Central Index Key: 0002127120
• ·39 total holdings with no other managers reported

22-04-2026

Churchill Financial Advisors, LLC filed its 13F-HR report on April 22, 2026, disclosing a diversified portfolio of 123 equity and ETF positions totaling 475826118 USD as of March 31, 2026. Top holdings by value include Walmart Inc COM at 124351958 USD (1000579 shares), Apple Inc COM at 24020462 USD (94647 shares), and State Street SPDR S&P 500 ETF (78462F103) at 16529854 USD (25417 shares), with all positions held solely. No period-over-period changes or performance metrics are provided in the filing.

• ·All holdings reported as SOLE with no shared or other discretion (0 0 0)
• ·Portfolio managed from 312 Whittington Parkway, Ste 201, Louisville, KY 40222
• ·SEC file number: 028-26141; CIK: 0002095935

22-04-2026

New Mountain Guardian IV Income Fund, L.L.C. furnished its portfolio investment allocation as of December 31, 2025, under Regulation FD, classifying investments into 11 industry types with sub-classifications representing percentages of total fair value. Business Services was the largest at 34.1%, followed by Software at 30.5%, Financial Services & Technology at 14.8%, and Healthcare at 10.3%. Remaining sectors including Consumer Services (4.5%), Education (3.3%), and others totaled 20.3%.

• ·Portfolio classified into 11 industry types for quarterly (Form 10-Q) and annual (Form 10-K) reporting.
• ·Disclosure date: April 22, 2026; portfolio as of December 31, 2025.
• ·Information furnished under Item 7.01, not deemed 'filed' under Section 18 of the Exchange Act.

22-04-2026

QUATTRO FINANCIAL ADVISORS LLC filed its 13F-HR report on April 22, 2026, disclosing $330,938,269 in total holdings as of March 31, 2026, across 91 positions, all held with sole voting power. The portfolio features diversified exposure to equities and ETFs, with top holdings including Microsoft Corp COM (55617 shares valued at $20,587,745), INVESCO EXCHANGE TRADED FD T S&P 500 TOP 50 (337753 shares at $18,424,426), and INVESCO QQQ TR UNIT SER 1 (29859 shares at $17,234,018). No period-over-period comparisons are available in this snapshot filing.

• ·One put option position: STATE STR SPDR S&P 500 ETF T PUT (397 shares valued at $784,640)
• ·Report filed under SEC file number 028-18064
• ·Business address: 1725 Hughes Landing Blvd. Suite 845, The Woodlands, TX 77380

22-04-2026

Parcion Private Wealth LLC filed its 13F-HR on April 22, 2026, disclosing $1,613,285,910 in total investments across 493 positions as of March 31, 2026. The portfolio includes significant holdings in large-cap stocks such as Apple Inc. ($38,068,002 for 149,998 shares), Alphabet Inc. Class A ($26,779,683 for 93,127 shares), and Amazon.com Inc. ($15,335,170 for 73,631 shares), alongside diversified ETFs and other equities. No period-over-period changes are detailed in this snapshot filing.

• ·Filing period end date: 2026-03-31
• ·Sub-advisors include PARAMETRIC PORTFOLIO ASSOCIATES LLC (801-60485) and Richard Bernstein Advisors LLC (801-71501)
• ·Portfolio includes ETFs such as American Century US Small Cap Value ETF (460,638 shares) and Dimensional Emerging Markets Core Equity ETF (2,677,850 shares)

22-04-2026

Nuveen Global Cities REIT, Inc. declared gross distributions of $0.06353547 per share for all classes of its common stock for record holders as of March 30, 2026. Net distributions after advisory and stockholder servicing fees range from $0.04396760 per share for Class T to $0.05735617 per share for Class N Common Stock. Distributions are payable on or about April 22, 2026, in cash or reinvested in shares for stockholders in the distribution reinvestment plan.

• ·Record date for distributions: March 30, 2026
• ·Distributions payable on or about April 22, 2026

22-04-2026

Shum Financial Group, Inc. submitted its 13F-HR filing on April 22, 2026, reporting institutional holdings as of March 31, 2026, with 93 positions totaling $141,426,337 in market value. The portfolio features significant exposure to large-cap technology stocks including Alphabet Inc., Apple Inc., Microsoft Corp., NVIDIA Corporation, and a variety of iShares and SPDR ETFs. No period-over-period changes or performance metrics are provided in the filing.